Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Penam Laboratories Limited, is an unlisted public company incorporated on 07 August, 1989. It is classified as a public limited company and is located in New Delhi, Delhi. It's authorized share capital is INR 11.00 cr and the total paid-up capital is INR 5.17 cr.
Penam Laboratories Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 64.0% over the previous year. At the same time, it's book networth has increased by 12.32%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Arun Mittal
Shareholder
|
00049425 | 32 years |
Whole-time Director | Ashish Ajmani
Shareholder
|
00130788 | 16 years |
Managing Director | Paras Nath Pandey
Shareholder
|
00150374 | 36 years |
Managing Director | Surender Kumar Ajmani
Shareholder
|
00466908 | 36 years |
Director | Raj Rani Ajmani
Shareholder
|
01134078 | 7 years |
Director | Abha Pandey
Shareholder
|
01149655 | 7 years |
Director | Narinder Mohan Jhanji
Shareholder
|
02612674 | 16 years |
Whole-time Director | Vikas Pandey
Shareholder
|
08836156 | 5 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
CHEMCAPS LIMITED |
Active
|
1.3 Cr | 1 | Delhi |
PRODERNA BIOTECH PRIVATE LIMITED |
Active
|
13,557.0 | 1 | Delhi |
CONTINENTAL MANUFACTURES PRIVATE LIMITED |
Active
|
8.8 L | 3 | Delhi |
SAMPARK OVERSEAS PRIVATE LIMITED |
Active
|
4.5 L | 2 | Delhi |
SAMPARK FINE CHEM PRIVATE LIMITED. |
Active
|
5.0 L | 1 | Delhi |
D KUMAR CONSULTING ENGINEERS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Delhi |
PHARMOCELL PRIVATE LIMITED |
Strike Off
|
2.8 L | 2 | Delhi |
Read more
The incorporation date of PENAM LABORATORIES LIMITED is 07 August, 1989
The authorized share capital of PENAM LABORATORIES LIMITED is INR ₹ 11.0 Cr.
The paid-up capital of PENAM LABORATORIES LIMITED is INR ₹ 5.2 Cr.
The registered address of PENAM LABORATORIES LIMITED is F-223 NEW RAJINDER NAGAR NEW DELHI Delhi - 110060
The CIN number of PENAM LABORATORIES LIMITED is U24231DL1989PLC037287.